1,234
Participants
Start Date
October 31, 2004
Celecoxib
Placebo
Loxoprofen
Pfizer Investigational Site, Kumagaya-shi
Pfizer Investigational Site, Kumagayashi
Pfizer Investigational Site, Funabashi
Pfizer Investigational Site, Funabashi-shi
Pfizer Investigational Site, Matsudo-shi
Pfizer Investigational Site, Fukuoka
Pfizer Investigational Site, Sapporo
Pfizer Investigational Site, Sagamihara-shi
Pfizer Investigational Site, Yokohama
Pfizer Investigational Site, Hatogaya-shi
Pfizer Investigational Site, Minamisaitama-gun
Pfizer Investigational Site, Saitama-shi
Pfizer Investigational Site, Tokorozawa
Pfizer Investigational Site, Adachi-Ku
Pfizer Investigational Site, Bunkyou-ku
Pfizer Investigational Site, Edogawa-ku
Pfizer Investigational Site, Itabashi-ku
Pfizer Investigational Site, Koito-ku
Pfizer Investigational Site, Meguro-Ku
Pfizer Investigational Site, Nakano-ku
Pfizer Investigational Site, Nerima-ku
Pfizer Investigational Site, Ōta-ku
Pfizer Investigational Site, Setagaya-ku
Pfizer Investigational Site, Shibuya-ku
Pfizer Investigational Site, Shinjyuku-ku
Pfizer Investigational Site, Suginami-ku
Pfizer Investigational Site, Toyoshima-ku
Pfizer Investigational Site, Fukuoka
Pfizer Investigational Site, Chitose
Pfizer Investigational Site, Katougun
Pfizer Investigational Site, Kobe
Pfizer Investigational Site, Nishinomiya
Pfizer Investigational Site, Ōta-ku
Pfizer Investigational Site, Shinagawa-ku
Pfizer Investigational Site, Sumida-ku
Pfizer Investigational Site, Chiba
Pfizer Investigational Site, Fukuoka
Pfizer Investigational Site, Tokyo
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY